Abstract:In this study, we examined chronic norepinephrine suppression of insulin secretion in sheep fetuses with placental insufficiency-induced intrauterine growth restriction (IUGR). Glucose-stimulated insulin secretion (GSIS) was measured with a square-wave hyperglycemic clamp in the presence or absence of adrenergic receptor antagonists phentolamine (alpha) and propranolol (beta). IUGR fetuses were hypoglycemic and hypoxemic and had lower GSIS responsiveness (P < or = 0.05) than control fetuses. IUGR fetuses also had elevated plasma norepinephrine (3,264 +/- 614 vs. 570 +/- 86 pg/ml; P < or = 0.05) and epinephrine (164 +/- 32 vs. 60 +/- 12 pg/ml; P < or = 0.05) concentrations. In control fetuses, adrenergic inhibition increased baseline plasma insulin concentrations (1.7-fold, P < or = 0.05), whereas during hyperglycemia insulin was not different. A greater (P < or = 0.05) response to adrenergic inhibition was found in IUGR fetuses, and the average plasma insulin concentrations increased 4.9-fold at baseline and 7.1-fold with hyperglycemia. Unlike controls, basal plasma glucose concentrations fell (P < or = 0.05) with adrenergic antagonists. GSIS responsiveness, measured by the change in insulin, was higher (8.9-fold, P < or = 0.05) in IUGR fetuses with adrenergic inhibition than controls (1.8-fold, not significant), showing that norepinephrine suppresses insulin secretion in IUGR fetuses. Strikingly, in IUGR fetuses, adrenergic inhibition resulted in a greater GSIS responsiveness, because beta-cell mass was 56% lower and the maximal stimulatory insulin response tended (P < 0.1) to be higher than controls. This persistent norepinephrine suppression appears to be partially explained by higher mRNA concentrations of adrenergic receptors alpha(1D), alpha(2A), and alpha(2B) in a cohort of fetuses that were naïve to the antagonists. Therefore, norepinephrine suppression of insulin secretion was maintained, in part, by upregulating adrenergic receptor expression, but the beta-cells also appeared to compensate with enhanced GSIS. These findings may begin to explain why IUGR infants have a propensity for increased glucose requirements if norepinephrine is suddenly decreased after birth.

Fetal Adrenal Demedullation Lowers Circulating Norepinephrine and Attenuates Growth Restriction but not Reduction of Endocrine Cell Mass in an Ovine Model of Intrauterine Growth Restriction

Adrenal Demedullation and Oxygen Supplementation Independently Increase Glucose-Stimulated Insulin Concentrations in Fetal Sheep with Intrauterine Growth Restriction.

Chronic Exposure to Elevated Norepinephrine Suppresses Insulin Secretion in Fetal Sheep with Placental Insufficiency and Intrauterine Growth Restriction.

The Effects of Intrauterine Undernutrition on Pancreas Ghrelin and Insulin Expression in Neonate Rats.

[Age-Dependent Alteration of Insulin and Ghrelin Expression in Pancreatic Islets of Intrauterine Growth-Retarded Rats].

Chronic Norepinephrine Suppression Induces a Compensatory B-Cell Adaptation That Enhances Insulin Secretion after Alleviation of the Catecholamine Inhibition in Fetal Sheep

Β2-Adrenergic Receptor Desensitization in Perirenal Adipose Tissue in Fetuses and Lambs with Placental Insufficiency-Induced Intrauterine Growth Restriction

The Levels of Pdx1/insulin, Cacna1c and Cacna1d, and Β-Cell Mass in a Rat Model of Intrauterine Undernutrition

Enhanced Insulin Secretion Responsiveness and Islet Adrenergic Desensitization after Chronic Norepinephrine Suppression is Discontinued in Fetal Sheep.

Anatomical and functional changes of the fetal adrenal gland in intrauterine growth restriction

Chronic Adrenergic Signaling Causes Abnormal RNA Expression of Proliferative Genes in Fetal Sheep Islets

Hypoxaemia-Induced Catecholamine Secretion From Adrenal Chromaffin Cells Inhibits Glucose-Stimulated Hyperinsulinaemia In Fetal Sheep

Consequences of intra-uterine growth retardation for postnatal growth, metabolism and pathophysiology.

Placental insufficiency decreases pancreatic vascularity and disrupts hepatocyte growth factor signaling in the pancreatic islet endothelial cell in fetal sheep

Islet Adaptations in Fetal Sheep Persist Following Chronic Exposure to High Norepinephrine.

A genetically small fetus impairs placental adaptations near term

Maternal nutrient restriction during early to mid gestation up-regulates cardiac insulin-like growth factor (IGF) receptors associated with enlarged ventricular size in fetal sheep.

IGF-1 infusion increases growth in fetal sheep when euinsulinemia is maintained

Effect of Intrauterine Growth Restriction During Late Pregnancy on the Growth Performance, Blood Components, Immunity and Anti-Oxidation Capability of Ovine Fetus

Metabolomic Analysis Reveals Differences In Umbilical Vein Plasma Metabolites Between Normal And Growth-Restricted Fetal Pigs During Late Gestation

Insulin-like growth factor and fibroblast growth factor expression profiles in growth-restricted fetal sheep pancreas.